First independent evaluation of QuantiFERON-TB Plus performance

European Respiratory Journal

Volumn 47, Issue 5, 2016, Pages 1587-1590

  Barcellini, Lucia ^a   Borroni, Emanuele ^a   Brown, James ^b   Brunetti, Enrico ^c   Codecasa, Luigi ^d   Cugnata, Federica ^e   Monte, Paola Dal ^f   Serio, Clelia Di ^e   Goletti, Delia ^g   Lombardi, Giulia ^f   Lipman, Marc ^b   Rancoita, Paola M V ^e   Tadolini, Marina ^f   Cirillo, Daniela M ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^d OSPEDALE NIGUARDA CA GRANDA   (Italy)

^e VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^f UNIVERSITY OF BOLOGNA   (Italy)

^g NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

ADULT; ANALYTICAL EQUIPMENT; ANTIGEN TUBE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CYTOKINE RELEASE; ELISA KIT; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPROMISED PATIENT; INTERFERON GAMMA RELEASE ASSAY; LATENT TUBERCULOSIS; LETTER; MAJOR CLINICAL STUDY; MALE; MEASUREMENT ACCURACY; MIXED INFECTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS; EVALUATION STUDY;

FEMALE; HUMANS; INTERFERON-GAMMA; MALE; TUBERCULOSIS;

EID: 84969802759     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.02033-2015     Document Type: Letter

References (13)

1. Diel R, Loddenkemper R, Zellweger J-P, et al. Old ideas to innovate TB control: preventive treatment to achieve elimination. Eur Respir J 2013; 42: 785-801.
2. Lonnroth K, Migliori GB, Abubakar I, et al. Towards tuberculosis elimination: An action framework for low-incidence countries. Eur Respir J 2015; 45: 928-952.
3. Sester M, Sotgiu G, Lange C, et al. Interferon-γ release assays for the diagnosis of active tuberculosis: A systematic review and meta-analysis. Eur Respir J 2011; 37: 100-111.
4. Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: An update. Ann Intern Med 2008; 149: 177-184.
5. Qiagen. QuantiFERONR-TB Gold Plus (QFTR-Plus) ELISA Package Insert. www.quantiferon.com/irm/content/PI/QFT/PLUS/2PK-Elisa/UK.pdf.
6. Rozot V, Vigano S, Mazza-Stalder J, et al. Mycobacterium tuberculosis-specific CD8+ T cells are functionally and phenotypically different between latent infection and active disease. Eur J Immunol 2013; 43: 1568-1577.
7. Nikolova M, Markova R, Drenska R, et al. Antigen-specific CD4- And CD8-positive signatures in different phases of Mycobacterium tuberculosis infection. Diagn Microbiol Infect Dis 2013; 75: 277-281.
8. Chiacchio T, Petruccioli E, Vanini V, et al. Polyfunctional T-cells and effector memory phenotype are associated with active TB in HIV-infected patients. J Infect 2014; 69: 533-545.
9. Lancioni C, Yendak M, Kiguli S, et al. CD8+ T cells provide an immunologic signature of tuberculosis in young children. Am J Respir Crit Care Med 2012; 185: 206-212.
10. Getahun H, Matteelli A, Abubakar I, et al. Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries. Eur Respir J 2015; 46: 1563-1576.
11. Day CL, Abrahams DA, Lerumo L, et al. Functional capacity of Mycobacterium tuberculosis-specific T cell responses in humans is associated with mycobacterial load. J Immunol 2011; 187: 2222-2232.
12. Losi M, Knights AJ, Mariani F, et al. QuantiFERON-TB performance enhanced by novel Mycobacterium tuberculosis-specific antigens. Eur Respir J 2016; 47: 660-664.
13. D'Ambrosio L, Dara M, Tadolini M, et al. Tuberculosis elimination: Theory and practice in Europe. Eur Respir J 2014; 43: 1410-1420.